KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
17 Avril 2024 - 1:00PM
Business Wire
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the
“Company”), a leading medical technology company focused on
development, manufacturing, and commercialization of innovative and
patient-centric large volume subcutaneous infusion solutions, today
announced that the Company will report first quarter 2024 financial
results on Wednesday, May 1, 2024. KORU Medical’s management will
host a conference call and webcast at 4:30 p.m. ET that day to
discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (877)-407-0784
for participants in the U.S. or Canada and (201)-689-8560 for
international callers. A live and archived webcast of the event can
be accessed via the IR Calendar on the News/Events page of the
Investors section of KORU Medical’s website at www.korumedical.com.
The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical develops, manufactures, and commercializes
innovative and patient-centric large volume subcutaneous infusion
solutions that improve quality of life for patients around the
world. The FREEDOM Syringe Infusion System (“the FREEDOM System”)
currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion
Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous
Safety Needle Sets™. These devices are used for infusions
administered in the home and alternate care settings. For more
information, please visit www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240410437582/en/
Investor: Greg Chodaczek 347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
KORU Medical Systems (NASDAQ:KRMD)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025
